(Q51360425)

4 April 2018

title

Safety of benznidazole use in the treatment of chronic Chagas' disease. (English)

1 reference

4 April 2018

0 references

1 reference

Alejandro M Hasslocher-Moreno

1

1 reference

4 April 2018

Pedro E A A do Brasil

2

1 reference

4 April 2018

Andrea S de Sousa

3

1 reference

4 April 2018

Sergio S Xavier

4

1 reference

4 April 2018

Mayara C Chambela

5

1 reference

4 April 2018

Gilberto M Sperandio da Silva

6

1 reference

4 April 2018

language of work or name

English

0 references

publication date

13 February 2012

1 reference

4 April 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

4 April 2018

volume

67

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

1261-1266

1 reference

4 April 2018

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Chagas disease: a Latin American health problem becoming a world health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Clinical and epidemiological aspects of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Chemotherapy of trypanosomiases and leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Adverse events after the use of benznidazole in infants and children with Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

Tolerance of benznidazole in treatment of Chagas' disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS027

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS027

1 reference

4 April 2018

PubMed ID

22331592

1 reference

4 April 2018